Early this year, British Columbia, Alberta, Saskatchewan, Quebec and Ontario announced the lowering of eligibility requirements for access to public coverage for life-changing hepatitis C drugs, including Epclusa, Zepatier, daclatasvir and asunaprevir. These drugs will be available to those with lower fibrosis scores for the first time (the greater the fibrosis score, the more severe the liver scarring, or cirrhosis, caused by disease.)[i]
The emergence of PrEP has highlighted important gender inequalities in HIV transmission and HIV prevention. PrEP, or pre-exposure prophylaxis, is a drug that HIV-negative people (including women!) can take to help prevent HIV; however, most discussions about PrEP focus on men. Despite representing fewer new HIV infections than men, women also need innovative HIV prevention methods.
Je me vois souvent contraint de commencer mes billets sur le travail du sexe en parlant du Grand Prix de F1 de Montréal.
Chaque année, dans la foulée du Grand Prix – et particulièrement l’année dernière, en juin – les médias se font un plaisir, sinon un devoir, de prendre d’assaut ce qu’ils perçoivent comme une violente augmentation de l’exploitation sexuelle et de la traite des femmes dans le cadre de ces évènements sportifs. Cette médiatisation s’inscrit dans une approche abolitionniste aux effets néfastes, ceux-ci incluant une surveillance accrue, des arrestations plus fréquentes et des risques de déportation plus élevés pour les travailleuse(-eur)s du sexe.
Good news? On this World AIDS Day, 2016, there is a lot to report.
The science of treatment and prevention has much to inspire agencies delivering needed services to people living with, and at risk of, HIV.
We know that there are significant health benefits for people with HIV to begin treatment as soon as possible after diagnosis. Early treatment with good adherence in order to maintain an undetectable viral load allows an HIV-positive person to live a long and healthy life. A ground-breaking study called START (Strategic Timing of Antiretroviral Treatment) found that immediate treatment upon an HIV diagnosis significantly reduced the risk of serious illness.
The Gardiner Museum of Ceramic Art, in partnership with the Toronto Community Hep C Program (TCHCP), invited people with lived experience of hepatitis C to take part in an art project called The Face of Our Story. In that project, clay tiles depicting stories of lived experience would be displayed at the museum on World Hepatitis Day, July 28, 2016. This is the story of Signe and Tom who participated in the event.
The day arrived when we met with museum staff, were given a tour, and the project was explained to us. We were nervous. We were proud to be part of this experience, but at the same time unsure of our surroundings and what was expected of us. None of us had ever put on an art show in a museum. We spoke in hushed tones and experienced a feeling of reverence as we saw the beautiful work of other artists. We exchanged glances and thought, “Uh oh! What are we doing here?”
The CATIE Blog hosts the views and opinions of people and organizations working and volunteering in Canada’s response to HIV and hepatitis C.